The Single-use Bioprocessing Market encompasses disposable, pre-sterilized biomanufacturing systems such as bioreactors, bags, filters, and tubing used to produce biologics, vaccines, and cell and gene therapies. These systems replace traditional stainless-steel equipment, providing greater flexibility, faster production times, lower contamination risk, reduced capital investment, and cost-efficient scalability, making them increasingly favored in biopharmaceutical manufacturing.
According to FutureWise analysis, the single-use bioprocessing market in 2026 is US$35.43 billion, and is expected to reach US$74.61 billion by 2036 at a CAGR of 7.73%. The single-use bioprocessing market is experiencing significant growth, driven by the increasing adoption of disposable technologies in biopharmaceutical manufacturing. These technologies provide greater flexibility and reduced contamination risks. Additionally, the rising demand for biologics and biosimilars, combined with the need for cost-effective and time-efficient production processes, is further driving the market.
Growth Drivers:
- Increasing demand for biologics, biosimilars, vaccines, and cell & gene therapies
- Rising adoption of flexible and modular biomanufacturing facilities
- Lower capital investment compared to traditional stainless-steel systems
- Reduced risk of cross-contamination and improved product safety
- Faster setup and turnaround time, improving production efficiency
Key Trends:
- Increasing adoption of single-use systems in large-scale commercial manufacturing
- Integration of advanced sensors and digital monitoring for real-time process control
- Growth of modular and flexible facility designs to support rapid capacity changes
- Expansion of automated and closed-loop bioprocessing solutions
- Rising preference for hybrid manufacturing approaches combining single-use and traditional systems
Market Segmentation and Key Players:
The Single-use Bioprocessing Market is segmented by product, application, end user, and region. Key products include single-use bioreactors, media bags, filtration assemblies, and disposable mixers. Applications cover cell culture, filtration, purification, storage, and sampling. End users consist of biopharmaceutical and biotechnology firms, as well as academic institutions. Geographically, the market spans North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa. Comprehensive segmentation details are provided in the Segmentation section below.
Major companies operating in the Single-use Bioprocessing Market Include Thermo Fisher Scientific, Sartorius Stedim Biotech, and Danaher Corporation.
Research Methodology:
The research methodology for the Single-use Bioprocessing Market by FutureWise Research combines extensive primary and secondary research. Secondary research collects data from industry reports, company annual reports, investor presentations, regulatory databases, and reputable publications to analyze historical trends and market structure. Primary research involves interviews with industry experts and key stakeholders to validate findings and obtain qualitative insights.